NCT00367731

NOW Thai HAART Study

Neurological Outcomes With in THAI National HAART Program.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 500 (planned)
• Sponsor: Department of Medical Services Ministry of Public Health of Thailand · Other Government
• Sex: All
• Age: 15 Years
• Healthy volunteers: Not accepted

Summary

After Initiation of HAART in peoples who living with HIV/AIDS in Thailand by the year 2000, rapidly expanded HAART access of national project has been promoted in 2004. Free ARVs (For CD4\<200cell/cu.mm. or in symptomatic HIV with CD4\<250 cell/cu.mm. )and CD4 monitoring has been available. The first-line regimen is d4T+3TC+NVP in mainly the first time (Naive) patients. CD4 response ), rate of opportunistic infection, and neurological outcomes were measured. Rate of ARV change, adverse events,treatment failure, TB co-infection rate, percent changing to EFV-based regimen or PI-based regimen were recorded. Any Adverse Events including, Sever rash, Severe Hepatitis, Lipid abnormalities, Severe Anemia and Other, common AEs will be analysed.

Conditions

• HIV
• AIDS
• Neurological Complications

Interventions

Type	Name	Description
DRUG	Highly Active Antiretroviral Treatment (combination of :NRTI, NNRTI,or PI)

Timeline

• Start date: 2005-01-01
• Completion: 2006-09-01
• First posted: 2006-08-23
• Last updated: 2006-08-23

Locations

3 sites across 1 country: Thailand